Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
Status:
Completed
Trial end date:
2021-05-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the safety and efficacy of TP-03, 0.25%, an eyedrop,
to its vehicle control for the treatment of blepharitis due to Demodex, a microscopic mite
frequently found in human hair follicles. The hypothesis for the study is the proportion of
participants cured at Day 43 with treatment by TP-03, 0.25%, is greater than the proportion
cured by treatment with its vehicle.